FDA NDC Directory · JSON-LD · Markdown

Neostigmine Methylsulfate

NDC 0641-6264 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA207042
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (.5 mg/mL)
Marketing started20151228
Package count1

External sources

Source: openFDA. Public-domain (CC0).